Skip to main content

Find Clinical Trials

Home
Conditions
Liver Neoplasms

Clinical trial condition

Liver Neoplasms

Explore clinical trials studying Liver Neoplasms. Study availability and eligibility vary by location and protocol.

1,743 public trials 464 recruiting studies

Refine in advanced search Browse all conditions

Liver Neoplasms trial results

Completed

Combination of GT90001 and Nivolumab in Patients With Metastatic Hepatocellular Carcinoma(HCC)

NCT03893695

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +11 more
Locations: National Cheng Kung University Hospital Tainan, Taiwan

MacKay Memorial Hospital Taipei, Taiwan

National TaiWan University Hospital Taipei, Taiwan

View Trial Details

Completed

Liver Resection for Patients With Hepatocellular Carcinoma and Clinically Significant Portal Hypertension

NCT06245798

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Tangdu hospital Xi'an, Shaanxi, China

Xijing hospital Xi'an, Shaanxi, China

View Trial Details

Completed

[18F]FMISO PET/CT After Transcatheter Arterial Embolization in Imaging Tumors in Patients With Liver Cancer

NCT02695628

Conditions: Adenocarcinoma, Adult Liver Carcinoma, Carcinoma, +13 more
Locations: VA Palo Alto Healthcare System Palo Alto, California, United States

View Trial Details

Completed

Association Between Pre-op Non-Selective Beta-Blockers and Hepatocellular Carcinoma Recurrence Post-Liver Transplant

NCT06233708

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations: Not specified

View Trial Details

Completed

Atezolizumab Plus Bevacizumab Versus Sintilimab Plus Bevacizumab With TACE and HAIC in Unresectable Hepatocellular Carcinoma

NCT06199297

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Wei He Guangzhou, Guangdong, China

View Trial Details

Completed

Adjuvant Entecavir or Tenofovir for Postoperative HBV-HCC

NCT02650271

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Department of Hepatobilliary Surgery, Affiliated Tumor of Guangxi University Nanning, Guangxi, China

View Trial Details

Completed

Study of Apatinib After Systemic Therapy in Patients With Hepatocellular Carcinoma(AHELP)

NCT02329860

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
Locations: Jiangsu hengrui medicine CO. LTD Lianyungang, Jiangsu, China

View Trial Details

Completed

Phase II Study of Concurrent Sorafenib and Intensity-modulated Radiotherapy (IMRT) for Advanced Hepatocellular Carcinoma

NCT03535259

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +14 more
Locations: Bo Chen Beijing, Beijing Municipality, China

View Trial Details

Completed

Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

NCT01004978

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States

Mayo Clinic in Arizona Scottsdale, Arizona, United States

University of Arizona Cancer Center-Orange Grove Campus Tucson, Arizona, United States

View all 281 locations

View Trial Details

Completed

Sorafenib Tosylate Following a Liver Transplant in Treating Patients With Liver Cancer

NCT01624285

Conditions: Adenocarcinoma, Adult Primary Hepatocellular Carcinoma, Carcinoma, +12 more
Locations: University of Alabama Birmingham, Alabama, United States

Jonsson Comprehensive Cancer Center Los Angeles, California, United States

University of Colorado Denver, Colorado, United States

Mount Sinai Hospital Hartford, Connecticut, United States

View all 21 locations

View Trial Details